P&G Plans to Invest Rs. 2,200 crore in Gujarat for a Psyllium Husk-based Laxative Medicine and Vicks Products

Procter & Gamble (P&G) plans to invest Rs. 2,000 crore in its premium psyllium husk-based laxative drug product and Rs. 200 crore in its Vicks range of products in Gujarat as part of its domestic and global business expansion, according to Gujarat..

Anil Mittal Announced as Registrar-cum-Secretary of PCI

The Pharmacy Council of India (PCI) has announced that Anil Mittal, the Council's deputy secretary, has been promoted to the position of Registrar-cum-Secretary. He took over as Registrar-cum-Secretary on December 1, 2022, following the voluntary...

Government Introduces Chemotherapy Services at 30 ESIC Hospitals

According to an official statement, the government has begun offering in-house chemotherapy services at 30 ESIC hospitals across the country. Union Minister for Labour and Employment Bhupender Yadav launched the chemotherapy services at the ESIC...

Saroja Pharma Industries' IPO Received 77% Subscription on the First Day of Bidding

Saroja Pharma Industries India's initial public offering was oversubscribed by 77 percent on the first day of bidding on August 31, with offers for 8.35 lakh equity shares received against an offer size of 10.84 lakh shares. Retail investors...

Gujarat is set to Receive a Rs 3,000 Crore Investment in the Pharmaceutical Sector

Gujarat, known as India's pharmacy, continues to attract significant investments in the pharmaceutical sector. According to top state government sources, applications for greenfield and brownfield investments totaling Rs 3,000 crore...

Philips to Manufacture Products for its Personal Health segment in India

Royal Philips, a major player in health technology, has announced an expansion of its manufacturing in India to include a broader range of the company's Personal Health product categories. Deeptha Khanna, EVP and Chief Business Leader,...

Sun Pharma intends to Spend 7-8 Percent of Sales on R&D this Fiscal Year

According to a senior corporate official, Sun Pharmaceutical Industries Ltd plans to invest 7-8% of its current fiscal year's sales on research and development efforts in order to significantly expand its product range across therapeutic areas...

India Allocates Rs 5,000 crore to Push Research in the Pharmaceutical and Medical technology Sectors

In a move aimed to promote research and development (R&D) across the pharmaceutical and medical technology sectors, the Union Health Ministry has allocated Rs. 5,000 crore for a period of five years. The allocated fund aims to push for research....

Omron Healthcare India intends to Double its Revenue in the Next Three to Five Years

Omron Healthcare India Pvt. Ltd., a subsidiary of Japanese company Omron Healthcare Co. Ltd., which is into the supply of home healthcare monitoring devices in India, is planning to double its revenue in 3 to 5 years, the company’s....

Karnataka Pharma accelerates its Worldwide Footprint with a Centre of Excellence to Boost Innovation

Karnataka Pharma is stepping up its efforts to strengthen its worldwide reach by establishing a Centre of Excellence to boost innovation. Because of its emphasis on unique medications, new drug delivery methods, and regulatory compliance,...

© 2024 India Pharma Outlook. All Rights Reserved.